1-13 of 13
T. M. de Witte
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Red Blood Cell Transfusion Intensity on Progression-Free Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS Registry

Louise De Swart, MD, Simon Crouch, MSc, PhD, Marlijn Hoeks, MD, Alex Smith, PhD, Saskia Langemeijer, MD PhD, Pierre Fenaux, MD PhD, Argiris Symeonidis, MD PhD, Jaroslav Cermak, MD PhD, Reinhard Stauder, MD, Moshe Mittelman, MD, Guillermo Sanz, MD, Eva Hellstrom-Lindberg, MD PhD, Luca Malcovati, MD, Mette Skov Holm, MD PhD, Ulrich Germing, MD, Krzysztof Madry, MD PhD, Antonio Medina de Almeida, MD PhD, Aurelia Tatic, MD, Aleksandar Savic, Njetočka Gredelj-Šimec, MD, Agnes Guerci Bresler, Dominic Culligan, MD, Raphael Itzykson, MD PhD, Odile Beyne-Rauzy, MD, Sophie Park, MD PhD, Corine van Marrewijk, PhD, Nicole M A Blijlevens, David T. Bowen, MD, T. M. de Witte, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1690.
https://doi.org/10.1182/blood.V130.Suppl_1.1690.1690
Published: 2017
Journal Articles

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

Curly Morris, MD, Simona Iacobelli, Gosta Gahrton, MD, Laurent Garderet, MD, Mary Drake, MBBCh, MD, Anja van Biezen, Mohamad Mohty, Didier Blaise, MD, Xavier Poiré, M.D, Marie José Kersten, Noel-Jean Milpied, MD, Stig Lenhoff, MD, PhD, Nigel H. Russell, MD, J.ürgen Finke, T. M. de Witte, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2008.
https://doi.org/10.1182/blood.V118.21.2008.2008
Published: 2011
Journal Articles

Value of Low Dose IL-2 as Maintenance Following Consolidation Treatment or Autologous Transplantation in Acute Myelogenous Leukemia (AML) Patients Aged 15-60 Years Who Reached CR After High Dose (HD-AraC) Vs Standard Dose (SD-AraC) Cytosine Arabinoside During Induction: Results of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups.

Roelof Willemze, MD, PhD, Stefan Suciu, Franco Mandelli, MD, Stijn J.M. Halkes, MD, PhD, Jean-Pierre Marie, MD, Boris Labar, MD, PhD, Adriano Venditti, MD, Petra Muus, MD, PhD, Martin Mistrik, MD, PhD, Bruno Rotoli, Domenico Magro, Lorella Melillo, Dominique Bron, Francesco Fabbiano, Dominik L.D. Selleslag, MD, Domenico Pastore, Silvia maria Trisolini, Paola Fazi, Christelle Vandermaelen, Liliana Baila, Marco Vignetti, Sergio Amadori, T. M. de Witte, Giovanna Meloni
Journal: Blood
Blood (2009) 114 (22): 791.
https://doi.org/10.1182/blood.V114.22.791.791
Published: 2009
Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

Mauricette Michallet, MD, PhD, Peter Dreger, MD, PhD, Laurent Sutton, MD, Ronald Brand, Sue Richards, Anja van Biezen, Mohamad Sobh, Pharm.M, Alois Gratwohl, MD, Karin Kolbe, MD, Claire E. Dearden, MD, Michael Hallek, T. M. de Witte, MD, PhD, Dietger W. Niederwieser, MD, Michel Leporrier, MD, Donald Milligan, MD
Journal: Blood
Blood (2009) 114 (22): 877.
https://doi.org/10.1182/blood.V114.22.877.877
Published: 2009
Journal Articles

European Registry for Low Risk and Intermediate-1 Risk MDS: Base Line Report On First 400 Registered Patients.

T. M. de Witte, Alex Smith, Jackie Droste, Pierre Fenaux, Argyris Symeonidis, Eva Hellstrom-Lindberg, MD, PhD, Guillermo Sanz, Jaroslav Cermak, Otilia Georgescu, Ulrich Germing, Marius MacKenzie, Reinhard Stauder, MD, Odile Beyne Rauzy, David T. Bowen, MD
Journal: Blood
Blood (2009) 114 (22): 3811.
https://doi.org/10.1182/blood.V114.22.3811.3811
Published: 2009
Journal Articles

Clinical Scale Generation of Functional Human Natural Killer Cells From Umbilical Cord Blood CD34-Positive Cells for Immunotherapy.

Jan Spanholtz, Marleen Tordoir, Carel Trilsbeek, Jos Paardekooper, Diana Eissens, Arnold van der Meer, Irma Joosten, Frank Preijers, T. M. de Witte, Nicolaas Schaap, MD, PhD, Harry Dolstra
Journal: Blood
Blood (2009) 114 (22): 2666.
https://doi.org/10.1182/blood.V114.22.2666.2666
Published: 2009
Journal Articles

Unrelated Cord Blood Transplantation (UCBT) in Adults with MDS or Secondary Acute Myeloblastic Leukemia (sAML): a Survey On Behalf of Eurocord and CLWP of EBMT.

Marie Robin, MD, Guillermo Sanz, Irina Ionescu, Bernard Rio, Anne Sirvent, Marc Renaud, MD, Enric Carreras, MD, PhD, Noel-Jean Milpied, MD, T. M. de Witte, Alessandra Picardi, MD, Eliane Gluckman, Nicolaus Kroger, Vanderson Rocha
Journal: Blood
Blood (2009) 114 (22): 1198.
https://doi.org/10.1182/blood.V114.22.1198.1198
Published: 2009
Journal Articles

Autologous and Allogeneic Stem Cell Transplantation for Richter's Transformation: A Retrospective Analysis From the Chronic Leukaemia Working Party and Lymphoma Working Party of the EBMT.

Kate Cwynarski, MD, PhD, Anja van Biezen, Ronald Brand, Marijke Scholten, Bernd Metzner, Mohamad Mohty, MD, PhD, Vladimir Koza, MD, Maija Itala-Remes, Fabio Ciceri, MD, Arnon Nagler, MD, T. M. de Witte, Anna Sureda, MD, PhD, Peter Dreger
Journal: Blood
Blood (2009) 114 (22): 3360.
https://doi.org/10.1182/blood.V114.22.3360.3360
Published: 2009
Journal Articles

Comparison of Allogeneic Stem Cell Transplantation and Best Supportive Care in Elderly Patients with Advanced MDS.

Nicolaus Kröger, Hein Putter, Ronald Brand, Andrea Kündgen, T. M. de Witte, Ulrich Germing
Journal: Blood
Blood (2009) 114 (22): 3363.
https://doi.org/10.1182/blood.V114.22.3363.3363
Published: 2009
Journal Articles

T-Cell Depletion in Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: A Retrospective EBMT Analysis.

Johannes Schetelig, Donald Milligan, MD, MBChB, Dietger Niederwieser, Liisa Volin, J. Maertens, Alois Gratwohl, Martin Bornhaeuser, Michel Van Gelder, MD, PhD, Ronald Brand, T. M. de Witte, Peter Dreger
Journal: Blood
Blood (2009) 114 (22): 2307.
https://doi.org/10.1182/blood.V114.22.2307.2307
Published: 2009
Journal Articles

Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Nicolaus Kröger, MD, Avichai Shimoni, Georgia Schilling, Rainer Schwerdtfeger, MD, Martin Bornhäuser, Arnon Nagler, Axel R. Zander, Marion Heinzelmann, Ronald Brand, Goesta Gahrton, MD, PhD, Currly Morris, Dietger Niederwieser, T. M. de Witte
Journal: Blood
Blood (2009) 114 (22): 2308.
https://doi.org/10.1182/blood.V114.22.2308.2308
Published: 2009
Journal Articles

Monosomal Karyotype Predicts Poor Outcome for MDS/sAML Patients with Chromosome 7 Abnormalities After Allogeneic Stem Cell Transplantation for MDS/sAML. A Study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Michel Van Gelder, MD, PhD, Johannes Schetelig, Liisa Volin, Johan Maertens, Gerard Socié, Eefke Petersen, MD, Henrike Thomssen, MD, Anja Biezen, Ronald Brand, T. M. de Witte, Nicolaus Kröger, MD
Journal: Blood
Blood (2009) 114 (22): 293.
https://doi.org/10.1182/blood.V114.22.293.293
Published: 2009
Journal Articles

Preclinical Ex-Vivo Generation of Clinical Relevant Amounts of NK Cells from CD34+ Progenitor Cells for Immunotherapy

Jan Spanholtz, T. M. de Witte, MD, PhD, Marleen Tordoir, Harry Dolstra
Journal: Blood
Blood (2008) 112 (11): 2916.
https://doi.org/10.1182/blood.V112.11.2916.2916
Published: 2008